GAMBARAN POLA PERESEPAN OBAT PENYAKITHEPATITIS B RAWAT INAP DI RSUP dr. SOERADJI TIRTONEGORO KLATEN TAHUN 2018

Tri, Widyastuti (2020) GAMBARAN POLA PERESEPAN OBAT PENYAKITHEPATITIS B RAWAT INAP DI RSUP dr. SOERADJI TIRTONEGORO KLATEN TAHUN 2018. Diploma thesis, Sekolah Tinggi Ilmu Kesehatan Nasional.

	Text Fulltext Tri Widyastuti.pdf Restricted to Repository staff only Download (1MB)
	Text KTI.pdf Download (510kB)

Abstract

Hepatitis B virus (HBV) infection is an infectious disease caused by the hepatitis B virus which can cause inflammation and even damage to liver cells. Indonesia is a country with the second highest endemicity of hepatitis B in the South East Asian Region (SEAR) after Myanmar. Soeradji Tirtonegor Klaten 2018 period. This research is a non-experimental descriptive study. Data collection was done retrospectively. Sampling technique using purposive sampling data obtained as many as 55 samples that meet the inclusion criteria. The results of this study obtained the characteristics of hepatitis B patients hospitalized most (74.55%), the most age group 46-55 years (38.18%), most comorbidities with dyspepsia (20%), the most common use of gastrointestinal drugs is ondancentron (12.12%), hepatoprotective drugs of curcuma (13.26%), most antivirals of tenofovir (60.00%).

Actions (login required)

View Item